| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.35 | 5e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.21 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.05 |